Left Ventricular Systolic DysfunctionTMADNCT04399447
Multicenter Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD)
An observational study of Left Ventricular Systolic Dysfunction and Healthy Volunteers, run by Weidong Ren at 76 sites in China.
Trial summary
To establish the range of TMADmid、TMADmidpt% by using tissue motion tracking of mitral annular displacement (TMAD), and to explore the influencing factors. Read more about this study
- Who is it for?
- Ages 18 to 79 yearsHealthy volunteers can take part
- Conditions the study is for
- Left Ventricular Systolic Dysfunction, Healthy Volunteers
- What is being tested?
- Echocardiography
- Type of treatment
- Surgery or procedure
- How many people
- 2,400 participants
- Where
- 76 sitesChina
- Study dates
- Jun 2020to 30 Sep 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 79 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: 2400 healthy adults with normal physical examination items will be selected from the physical examination center. According to sex and age stratification, totally 2400 cases will contain 1200 males and 1200 females. From 18 to 79 years old, they will be divided into 6 groups: 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years and 70-79 years (n=400 per group).
Who may be able to join
- Han nationality
- Ages 18-79.
- Normal body mass index (18-25kg / m2).
- Normal blood pressure (139-90 / 89-60mmHg).
- No history of cardiovascular and respiratory diseases.
- No abnormality was found in physical examination of cardiovascular and respiratory system.
Show all 9Show fewer
- Blood glucose, lipid profile and electrocardiogram were normal.
- Echocardiography showed no structural heart disease and normal heart function.
- No history of medications affecting cardiovascular system.
Who cannot join
- Clinically significant or moderate heart valve regurgitation.
- Respiratory diseases: acute or chronic respiratory diseases.
- Endocrine diseases: thyroid disease, diabetes, hyperaldosteronism, pheochromocytoma, and abnormal adrenal function.
- Anemia.
- Pregnant or lactating women.
- Abnormal liver function (glutamyl aminotransferase exceeds 2.0 times the upper limit of normal value), abnormal renal function (creatinine exceeds the normal value), increased blood lipids (triglycerides, total cholesterol, low density and high density lipoprotein, any of which is higher than Normal value).
Show all 12Show fewer
- Connective tissue disease.
- Tumor.
- Aortic and peripheral vascular diseases: aortic dilatation, aortic dissection, aortic constriction, multiple arteritis, and atherosclerosis.
- Drink more than 50ml of white wine daily; more than 100ml of red wine; more than 300ml of beer.
- Professional athletes.
- The poor quality of the ultrasound image cannot satisfy the parameter measurement and analysis.
Trial locations and contacts
76 sites in 1 country.
76 sites in 1 country
China76 sites, 76 recruiting
- Recruiting
Baicheng Central Hospital
Baicheng, Jilin
Fan Zhang, 13943623116
Fan Zhang
- Recruiting
Affiliated Hospital of YouJiang Medical University for Nationalities
Baise City, Guangxi
Chengcai Chen, 13977617591
Chengcai Chen
- Recruiting
People'S Hospital of Baise
Baise City, Guangxi
Maoyi Li, 18677628852
Maoyi Li
- Recruiting
Gansu Baiyin Second People's Hospital
Baiyin, Gansu
Xinjian Yang, 13619308289
Xinjian Yang
- Recruiting
Baoji Central Hospital
Baoji, Shanxi
Guoliang Dun, 13509176168
Guoliang Dun
- Recruiting
The First Affiliated Hospital of Baotou Medical College
Baotou, Inner Mongolia
Guozhen Yan, 18547218068
Guozhen Yan
- Recruiting
Benxi Central Hospital
Benxi, Liaoning
Xingbin Wang, 18941435757
Xingbin Wang
- Recruiting
People'S Hospital of Hunan Province
Changsha, Hunan
Kun Ao, 13467511183
Kun Ao
- Recruiting
Chaoyang Central Hospital
Chaoyang, Liaoning
Suli Zhang, 18040159891
Suli Zhang
- Recruiting
Fengning Manchu Autonomous County Hospital
Chengde, Hebei
Dongsheng Zhao, 13483872058
Dongsheng Zhao
- Recruiting
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Chengdu, Sichuan
Yu Kang
Yu Kang
- Recruiting
Chengdu First People's Hospital
Chengdu, Sichuan
Xinyun Chen, 18011390127
Xinyun Chen
- Recruiting
Chengdu Second People'S Hospital
Chengdu, Sichuan
Yun Shi, 13658051337
Yun Shi
- Recruiting
Chengdu Third People's Hospital
Chengdu, Sichuan
Feng Xiong
Feng Xiong
- Recruiting
The Peoplep'S Hospital of Wenjiang District,Chengdu
Chengdu, Sichuan
Jing Tan, 13708204839
Jing Tan
- Recruiting
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality
Fang Li, 13808312288
Fang Li
- Recruiting
The People'S Hospital of Chong Zuo
Chongzuo, Guangxi
Mei Li, 13807873360
Mei Li
- Recruiting
Dali Bai Autonomous Prefecture People'S Hospital
Dali, Yunnan
Yan Cui, 13987275528
Yan Cui
- Recruiting
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, 116011
Tao Cong, 18098875836
Tao Cong
- Recruiting
Dalian Municipal Central Hospital
Dalian, Liaoning, 116033
Xiaofang Pan, 13591327871
Xiaofang Pan
- Recruiting
The Second Affiliated Hospital of Dalian Medical University
Dalian, Liaoning
Jun Wu, 13942022794
Jun Wu
- Recruiting
DanDong central hospital
Dandong, Liaoning
Xin Jin, 13842580705
Xin Jin
- Recruiting
The First People's Hospital of Foshan City
Foshan, Guangdong
Yuqiong Lai, 13809859038
Yuqiong Lai
- Recruiting
Fuchun Central Hospital
Fushun, Liaoning
Chen Zhang, 13941314545
Chen Zhang
- Recruiting
General Hospital of Fushun Mining Bureau
Fushun, Liaoning
Chunfeng Wang, 15694239647
Chunfeng Wang
- Recruiting
The People's Hospital of Gaozhou
Gaozhou, Guangdong
Guoxiong Wei, 13580011299
Guoxiong Wei
- Recruiting
West China-Guang'An Hospital,Sichuan University
Guang’an, Sichuan
Shuwen Chen, 13550980666
Shuwen Chen
- Recruiting
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong
Pengtao Sun, 18620168536
Pengtao Sun
- Recruiting
Guigang City People'S Hospital
Guigang, Guangxi
Zongxin Tao, 13737559953
Zongxin Tao
- Recruiting
The First Affiliated Hospital of Hainan Medical University
Haikou, Hainan
Ruixia Nan, 13036006449
Ruixia Nan
- Recruiting
Handan First Hospital
Handan, Hebei
Shaobo Wang, 15631006699
Shaobo Wang
- Recruiting
Hanzhong Central Hospital
Hanzhong, Shanxi
Zipeng Liu, 13084899536
Zipeng Liu
- Recruiting
Anhui Provincial Hospital
Hefei, Anhui
Haoyi Yang, 13720360838
Haoyi Yang
- Recruiting
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia
Xiaoshan Zhang, 13947133133
Xiaoshan Zhang
- Recruiting
The First People's Hospital of Huaihua
Huaihua, Hunan
Rui Zhang, 13973099796
Rui Zhang
- Recruiting
Jilin Central General Hospital
Jilin City, Jilin
Bing Gong, 15543430477
Bing Gong
- Recruiting
The Second Hospital of Shandong University
Jinan, Shandong
Yongmei Wang, 15153169591
Yongmei Wang
- Recruiting
The First Affiliated Hospital of Jinzhou Medical University
Jinzhou, Liaoning
Yuhong Li, 13940637604
Yuhong Li
- Recruiting
Jiujiang University Affiliated Hospital
Jiujiang, Jiangxi
Xuehua Xiao, 13517920820
Xuehua Xiao
- Recruiting
Laibin People's Hospital
Laibin, Guangxi
Xianling Mo, 18907828711
Xianling Mo
- Recruiting
The People's Hospital Of Leshan
Leshan, Sichuan
Ying Liu, 17628182552
Ying Liu
- Recruiting
Liaocheng People'S Hospital
Liaocheng, Shandong
Yilin Liu, 13346251883
Yilin Liu
- Recruiting
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan
Jizhu Xia, 18715770806
Jizhu Xia
- Recruiting
Mudanjiang Cardiovascular Hospital
Mudanjiang, Heilongjiang
Guangyu Gao, 13704838773
Guangyu Gao
- Recruiting
Affiliated Hospital of North Sichuan Medical College
Nanchong, Sichuan
Wensheng Yue, 13690767960
Wensheng Yue
- Recruiting
Nanchong Central Hospital
Nanchong, Sichuan
Xuebin Liu, 15882613551
Xuebin Liu
- Recruiting
Guangxi International Zhuang Medical Hospital
Nanning, Guangxi
Minhua Chen, 13517689974
Minhua Chen
- Recruiting
Guangxi Minzu Hospital
Nanning, Guangxi
Haiqing Su, 13978827211
Haiqing Su
- Recruiting
Nanyang Second People's Hospital
Nanyang, He'nan
Xu meng Ding, 13503779799
Xu meng Ding
- Recruiting
Panzhihua Central Hospital
Panzhihua, Sichuan
Xiaoli Wu, 13982323405
Xiaoli Wu
- Recruiting
Qingyuan People's Hospital
Qingyuan, Guangdong
Liwen Wu, 13802896000
Liwen Wu
- Recruiting
The Third Affiliated Hospital of Qiqihar Medical Hospital
Qiqihar, Heilongjiang
Xiao Liang, 13846283727
Xiao Liang
- Recruiting
Shanghai Pudong New District Zhoupu Hospital
Shanghai, Shanghai Municipality
Ye Song, 13818086439
Ye Song
- Recruiting
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004
Weidong Ren, 18940251657, renwd01@163.com
Lu Sun
- Recruiting
Central Hospital Affiliated To ShenYang Medical College
Shenyang, Liaoning
Tong Zang, 18002477367
Tong Zang
- Recruiting
The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Shenyang, Liaoning
Linwei Hong, 18040041999
Linwei Hong
- Recruiting
The First Hospital of China Medical University
Shenyang, Liaoning
Jun Yang, 13840266962
Jun Yang
- Recruiting
The People'S Hospital of Liaoning Province
Shenyang, Liaoning
Fang Zhu, 17702485777
Fang Zhu
- Recruiting
the Second Affiliated Hospital Of Shenyang Medical College
Shenyang, Liaoning
Jie Liu, 18002452866
Jie Liu
- Recruiting
First Affiliated Hospital,School of Medical,Shihezi University
Shihezi, Xinjiang
Guilin Lu, 13899527866
Guilin Lu
- Recruiting
shijiazhuang No.1 Hospital
Shijiazhuang, Hebei
Xiaoqing Yang, 17603119685
Xiaoqing Yang
- Recruiting
The Fourth Hospital of Heibei Medical University Hebei Cancer Hospital
Shijiazhuang, Hebei
Xiaohong Gong, 13831110712
Xiaohong Gong
- Recruiting
Suining Central Hospital
Suining, Sichuan
Xiaoyong Luo, 18008258086
Xiaoyong Luo
- Recruiting
Tangshan fengnan district hospital
Tangshan, Hebei
Yihong Li, 19931565611
Yihong Li
- Recruiting
Urumqi Friendship Hospital
Ürümqi, Xinjiang
Baoling Wang, 13579235938
Baoling Wang
- Recruiting
Shaanxi Provincial People'S Hospital
Xi’an, Shanxi
Xiangping Guan, 13991979638
Xiangping Guan
- Recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi
Litao Ruan, 13572815126
Litao Ruan
- Recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi
Shun Wang, 18991232635
Shun Wang
- Recruiting
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi
Qi Zhou, 18966896600
Qi Zhou
- Recruiting
Xianyang Central Hospital
Xianyang, Shanxi
Lei Cui, 13809141343
Lei Cui
- Recruiting
Xingtai Third Hospital
Xingtai, Hebei
Hongbing Peng, 13131991001
Hongbing Peng
- Recruiting
Qinghai Provincial People's Hospital
Xining, Qinghai
Haixia Sun, 18597015698
Haixia Sun
- Recruiting
Yantai Affiliated Hospital of Binzhou Medical University
Yantai, Shandong
Jiange Li, 18363805900
Jiange Li
- Recruiting
General Hospital of Ningxia Medical University
Yinchuan, Ningxia
Lisha Na, 13995376025
Lisha Na
- Recruiting
The first peopel's hospital of yulin
Yulin, Guangxi
Hongxia Yin, 18977585936
Hongxia Yin
- Recruiting
Zibo City Linzi District People's Hospital
Zibo, Shandong
Ying Liu, 17660292589
Ying Liu
About this study
Official title: The Multi-center Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD) in Chinese Han Adults Study
To establish the range of TMADmid、TMADmidpt% by using tissue motion tracking of mitral annular displacement (TMAD), and to explore the influencing factors.
Read the detailed description
With the gradual aging of Chinese population and continuous development of economy and society, the incidence of cardiovascular disease and the number of patients have increased rapidly. The National Heart Center has reported that the number of patients with clinically diagnosed cardiovascular disease in China has reached 290 million in 2016 (240 million in 2014). Cardiovascular disease is the most common cause of death in humans. Left ventricular systolic function plays an important role in the treatment and prognosis of patients with myocardial diseases. Early sensitive detection of left ventricular systolic function, timely treatment and early evaluation of the therapeutic effect can greatly reduce the death of patients with myocardial diseases rate.
At present, the left ventricular ejection fraction (LVEF), measured by the two-plane Simpson method in clinical, is one of the methods to evaluating left ventricular systolic function. It is especially suitable for patients with geometric deformation of the left ventricle, but some early heart failure patients' LVEF is still in the normal range, whose systolic function has been reduced, but. In recent years, 2D longitudinal strain is one of the indicators for evaluating left ventricular systolic function. The researchers believe that 70% of cardiac function is obtained by longitudinal movement of myocardium , which can be used as a good indicator for identifying myocardial diseases. However, both the two-plane Simpson method and the 2D longitudinal strain require good sound transmission conditions and good image quality. You can clearly see the endocardium and epicardium. Not all of patients in the clinic can get better image.
Basic and clinical studies and clinical statistics show that tissue motion tracking of mitral annular displacement (TMAD) is not affected by image quality and can effectively evaluate left ventricular systolic function. It can measure the mitral valve annulus displacement by marking the mitral valve annulus point and the reference point, which can quickly and accurately evaluate the left ventricular longitudinal contraction function.
- Being tested
- Echocardiography
- Keywords
- systolic function, left ventricular, normal
- Medical subject headings
- Ventricular Dysfunction, Left
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EchocardiographyRadiation
left ventricular systolic function of all participants were measured by tissue motion tracking of mitral annular displacement using PHILIPS
| Study group | Role | What they receive |
|---|---|---|
| 18-29 year-old group | Based on the inclusion crtiteria, 200 healthy Han people at aged 18-29 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. Receives: Radiation: Echocardiography | |
| 30-39 year-old group | Based on the inclusion crtiteria, 200 healthy Han people at aged 30-39 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. Receives: Radiation: Echocardiography | |
| 40-49 year-old group | Based on the inclusion crtiteria, 200 healthy Han people at aged 40-49 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. Receives: Radiation: Echocardiography | |
| 50-59 year-old group | Based on the inclusion crtiteria, 200 healthy Han people at aged 50-59 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. Receives: Radiation: Echocardiography | |
| 60-69 year-old group | Based on the inclusion crtiteria, 200 healthy Han people at aged 60-69 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. Receives: Radiation: Echocardiography | |
| 70-79 year-old group | Based on the inclusion crtiteria, 200 healthy Han people at aged 70-79 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. Receives: Radiation: Echocardiography |
What is being measured
The primary outcome is the main question the study is designed to answer.
left ventricular systolic function was measured by tissue motion tracking of mitral annular displacement(TMAD)
To establish the range of TMADmid by using TMAD
Measured: 1 day
left ventricular systolic function was measured by tissue motion tracking of mitral annular displacement(TMAD)
To establish the range of TMADmidpt% by using TMAD
Measured: 1 day
Secondary outcomes (1)
left ventricular systolic function was measured by the two-plane Simpson method
the left ventricular ejection fraction measured by the two-plane Simpson method, is the standard of the clinical
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2020
- Study startJun 2020 (estimated)
- Primary completion30 Jun 2021 (estimated)
- Study completion30 Sep 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Left Ventricular Systolic DysfunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 2,400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Weidong Ren
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Weidong Ren, Shengjing Hospital
- Investigators
- Weidong Ren, Principal investigator, Shengjing Hospital of China Medical Univeristy
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04399447
- Sponsor's protocol ID
- ShengJing Hospital Ultrasound
- Acronym
- TMAD
- Status last verified
- May 2020
- First submitted
- 9 May 2020
- Last updated
- 22 May 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 22 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Multi-center Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD) in Chinese Han Adults Study
- ClinicalTrials.gov ID
- NCT04399447
- Acronym / sponsor ID
- TMAD / ShengJing Hospital Ultrasound
- Keywords
- systolic function, left ventricular, normal
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 2,400 participants (estimated)
- Lead sponsor
- Weidong RenUniversity, hospital or other
- Study start
- Jun 2020 (estimated)
- Primary completion
- 30 Jun 2021 (estimated)
- Study completion
- 30 Sep 2021 (estimated)
- First posted
- 22 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To establish the range of TMADmid、TMADmidpt% by using tissue motion tracking of mitral annular displacement (TMAD), and to explore the influencing factors.
Detailed description
With the gradual aging of Chinese population and continuous development of economy and society, the incidence of cardiovascular disease and the number of patients have increased rapidly. The National Heart Center has reported that the number of patients with clinically diagnosed cardiovascular disease in China has reached 290 million in 2016 (240 million in 2014). Cardiovascular disease is the most common cause of death in humans. Left ventricular systolic function plays an important role in the treatment and prognosis of patients with myocardial diseases. Early sensitive detection of left ventricular systolic function, timely treatment and early evaluation of the therapeutic effect can greatly reduce the death of patients with myocardial diseases rate.
At present, the left ventricular ejection fraction (LVEF), measured by the two-plane Simpson method in clinical, is one of the methods to evaluating left ventricular systolic function. It is especially suitable for patients with geometric deformation of the left ventricle, but some early heart failure patients' LVEF is still in the normal range, whose systolic function has been reduced, but. In recent years, 2D longitudinal strain is one of the indicators for evaluating left ventricular systolic function. The researchers believe that 70% of cardiac function is obtained by longitudinal movement of myocardium , which can be used as a good indicator for identifying myocardial diseases. However, both the two-plane Simpson method and the 2D longitudinal strain require good sound transmission conditions and good image quality. You can clearly see the endocardium and epicardium. Not all of patients in the clinic can get better image.
Basic and clinical studies and clinical statistics show that tissue motion tracking of mitral annular displacement (TMAD) is not affected by image quality and can effectively evaluate left ventricular systolic function. It can measure the mitral valve annulus displacement by marking the mitral valve annulus point and the reference point, which can quickly and accurately evaluate the left ventricular longitudinal contraction function.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| 18-29 year-old group | – | Radiation: EchocardiographyBased on the inclusion crtiteria, 200 healthy Han people at aged 18-29 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. |
| 30-39 year-old group | – | Radiation: EchocardiographyBased on the inclusion crtiteria, 200 healthy Han people at aged 30-39 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. |
| 40-49 year-old group | – | Radiation: EchocardiographyBased on the inclusion crtiteria, 200 healthy Han people at aged 40-49 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. |
| 50-59 year-old group | – | Radiation: EchocardiographyBased on the inclusion crtiteria, 200 healthy Han people at aged 50-59 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. |
| 60-69 year-old group | – | Radiation: EchocardiographyBased on the inclusion crtiteria, 200 healthy Han people at aged 60-69 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. |
| 70-79 year-old group | – | Radiation: EchocardiographyBased on the inclusion crtiteria, 200 healthy Han people at aged 70-79 and both sexes will be recruited in the analysis. Normal reference values of tissue motion tracking of mitral annular displacement will be obtained. |
Who may qualify
- Ages
- 18 to 79 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- 2400 healthy adults with normal physical examination items will be selected from the physical examination center. According to sex and age stratification, totally 2400 cases will contain 1200 males and 1200 females. From 18 to 79 years old, they will be divided into 6 groups: 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years and 70-79 years (n=400 per group).
Key inclusion criteria (9 listed)
- Han nationality
- Ages 18-79.
- Normal body mass index (18-25kg / m2).
- Normal blood pressure (139-90 / 89-60mmHg).
- No history of cardiovascular and respiratory diseases.
Key exclusion criteria (12 listed)
- Clinically significant or moderate heart valve regurgitation.
- Respiratory diseases: acute or chronic respiratory diseases.
- Endocrine diseases: thyroid disease, diabetes, hyperaldosteronism, pheochromocytoma, and abnormal adrenal function.
- Anemia.
- Pregnant or lactating women.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Echocardiographyleft ventricular systolic function of all participants were measured by tissue motion tracking of mitral annular displacement using PHILIPS | Radiation | 18-29 year-old group, 30-39 year-old group, 40-49 year-old group, 50-59 year-old group, 60-69 year-old group, 70-79 year-old group |
Primary outcome
left ventricular systolic function was measured by tissue motion tracking of mitral annular displacement(TMAD)
Time frame: 1 day
To establish the range of TMADmid by using TMAD
left ventricular systolic function was measured by tissue motion tracking of mitral annular displacement(TMAD)
Time frame: 1 day
To establish the range of TMADmidpt% by using TMAD
1 secondary outcome
left ventricular systolic function was measured by the two-plane Simpson method
Time frame: 1 day
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 May 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Left Ventricular Systolic Dysfunction
RecruitingPhase 2/3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart Failure, Left Ventricular Systolic Dysfunction
Not yet recruitingObservational study
Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
Coronary Artery Disease, Left Ventricular Systolic Dysfunction
RecruitingPhase 3
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Coronary Artery Disease, Heart Failure Systolic
RecruitingPhase 3
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Weidong Ren principal investigator
Shengjing Hospital of China Medical Univeristy
76 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Left Ventricular Systolic Dysfunction and Healthy Volunteers, run by Weidong Ren at 76 sites in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 76 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Weidong Ren (8618940251657, renwd01@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
left ventricular systolic function was measured by tissue motion tracking of mitral annular displacement(TMAD) (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2020.